Informations techniques
Exploitant
Laboratoires PROSTRAKAN PHARMA
Présentation
DROLEPTAN 2,5 mg/ 1ml, solution injectable (IV) B/10 - CIP 561 122-8
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
WTjbH9y6bMca0Cd0